Mitophagy: A Bridge Linking HMGB1 and Parkinson’s Disease Using Adult Zebrafish as a Model Organism

Mitophagy: A Bridge Linking HMGB1 and Parkinson’s Disease Using Adult Zebrafish as a Model Organism

High-mobility group box 1 (HMGB1) has been implicated as a key player in two critical factors of Parkinson’s disease (PD): mitochondrial dysfunction and neuroinflammation. However, the specific role of HMGB1 in PD remains elusive. We investigated the effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyr...

Full description

Bibliographic Details
Main Authors:	Khairiah Razali, Mohd Hamzah Mohd Nasir, Jaya Kumar, Wael M. Y. Mohamed
Format:	Article
Language:	English
Published:	MDPI AG 2023-07-01
Series:	Brain Sciences
Subjects:	Parkinson’s disease high-mobility group box 1 MPTP mitochondrial dysfunction neuroinflammation zebrafish
Online Access:	https://www.mdpi.com/2076-3425/13/7/1076

Similar Items

High-Mobility Group Box 1 (HMGB1) Protein in Parkinson's Disease Research: A 10-Year Bibliometric Analysis
by: Khairiah Razali, et al.
Published: (2023-07-01)

The Transcription Factor Nrf2 Mediates the Effects of <i>Antrodia camphorata</i> Extract on Neuropathological Changes in a Mouse Model of Parkinson’s Disease
by: Marika Lanza, et al.
Published: (2023-05-01)

Anti-Inflammatory Effects of the Novel Barbiturate Derivative MHY2699 in an MPTP-Induced Mouse Model of Parkinson’s Disease
by: Seulah Lee, et al.
Published: (2021-11-01)

Mitochondrial dysfunction in Parkinson’s disease – a key disease hallmark with therapeutic potential
by: Martin T. Henrich, et al.
Published: (2023-11-01)

Voltage-Gated Proton Channel Hv1 Regulates Neuroinflammation and Dopaminergic Neurodegeneration in Parkinson’s Disease Models
by: Matthew L. Neal, et al.
Published: (2023-02-01)

A New Tool to Study Parkinsonism in the Context of Aging: MPTP Intoxication in a Natural Model of Multimorbidity
by: Lorena Cuenca-Bermejo, et al.
Published: (2021-04-01)

Neuroprotective Effects of the DPP4 Inhibitor Vildagliptin in In Vivo and In Vitro Models of Parkinson’s Disease
by: Ramesh Pariyar, et al.
Published: (2022-02-01)

The Effect of Aqueous Extract of Rosemary )Rosmarinus officinalis) on Parkinson\'s Disease Induced by MPTP in Male Mice
by: Mohammad Amani, et al.
Published: (2023-03-01)

MPTP-Treated Zebrafish Recapitulate ‘Late-Stage’ Parkinson’s-like Cognitive Decline
by: Alim A. O. Bashirzade, et al.
Published: (2022-02-01)

Mfn2 Overexpression Attenuates MPTP Neurotoxicity In Vivo
by: Fanpeng Zhao, et al.
Published: (2021-01-01)

Chemical and Genetic Zebrafish Models to Define Mechanisms of and Treatments for Dopaminergic Neurodegeneration
by: Ola Wasel, et al.
Published: (2020-08-01)

Combined Ubisol-Q<sub>10</sub> and Ashwagandha Root Extract Target Multiple Biochemical Mechanisms and Reduces Neurodegeneration in a Paraquat-Induced Rat Model of Parkinson’s Disease
by: Caleb Vegh, et al.
Published: (2021-04-01)

Studying the Pathophysiology of Parkinson’s Disease Using Zebrafish
by: Lisa M. Barnhill, et al.
Published: (2020-07-01)

Ncx3-Induced Mitochondrial Dysfunction in Midbrain Leads to Neuroinflammation in Striatum of A53t-α-Synuclein Transgenic Old Mice
by: Rossana Di Martino, et al.
Published: (2021-07-01)

Influence of Microbial Metabolites on the Nonspecific Permeability of Mitochondrial Membranes under Conditions of Acidosis and Loading with Calcium and Iron Ions
by: Nadezhda Fedotcheva, et al.
Published: (2021-05-01)

The Effects of Serping1 siRNA in α-Synuclein Regulation in MPTP-Induced Parkinson’s Disease
by: Min Hyung Seo, et al.
Published: (2023-07-01)

The Potentiality of Natural Products and Herbal Medicine as Novel Medications for Parkinson’s Disease: A Promising Therapeutic Approach
by: Yu-Jin So, et al.
Published: (2024-01-01)

Exploring the Neuroprotective Mechanism of Curcumin Inhibition of Intestinal Inflammation against Parkinson’s Disease Based on the Gut-Brain Axis
by: Lifan Zhong, et al.
Published: (2022-12-01)

<i>Srpk3</i> Decrease Associated with Alpha-Synuclein Increase in Muscles of MPTP-Induced Parkinson’s Disease Mice
by: Min Hyung Seo, et al.
Published: (2021-08-01)

Association between Decreased ITGA7 Levels and Increased Muscle α-Synuclein in an MPTP-Induced Mouse Model of Parkinson’s Disease
by: Sangeun Han, et al.
Published: (2022-05-01)

A Pilot Study of Changes in the Level of Catecholamines and the Activity of α-2-Macroglobulin in the Tear Fluid of Patients with Parkinson’s Disease and Parkinsonian Mice
by: Vsevolod Bogdanov, et al.
Published: (2021-04-01)

Berberine Induces Mitophagy through Adenosine Monophosphate-Activated Protein Kinase and Ameliorates Mitochondrial Dysfunction in PINK1 Knockout Mouse Embryonic Fibroblasts
by: Jee-Hyun Um, et al.
Published: (2023-12-01)

Lactoferrin: neuroprotection against Parkinson's disease and secondary molecule for potential treatment
by: Furkan Eker, et al.
Published: (2023-09-01)

Significance of Mitochondrial Dysfunction in the Pathogenesis of Parkinson's Disease
by: Alexander Blagov, et al.
Published: (2024-01-01)

Changes in Tyrosine Hydroxylase Activity and Dopamine Synthesis in the Nigrostriatal System of Mice in an Acute Model of Parkinson’s Disease as a Manifestation of Neurodegeneration and Neuroplasticity
by: Anna Kolacheva, et al.
Published: (2022-06-01)

Ipconazole Disrupts Mitochondrial Homeostasis and Alters GABAergic Neuronal Development in Zebrafish
by: Giyoung Lee, et al.
Published: (2022-12-01)

YKL-40 and the Cellular Metabolic Profile in Parkinson’s Disease
by: Maria Gevezova, et al.
Published: (2023-11-01)

The alleviative effect of Calendula officinalis L. extract against Parkinson’s disease-like pathology in zebrafish via the involvement of autophagy activation
by: Mengfei Wang, et al.
Published: (2023-04-01)

Decrease in <i>ITGA7</i> Levels Is Associated with an Increase in α-Synuclein Levels in an MPTP-Induced Parkinson’s Disease Mouse Model and SH-SY5Y Cells
by: Sangeun Han, et al.
Published: (2021-11-01)

Expression Analysis of Genes Involved in Transport Processes in Mice with MPTP-Induced Model of Parkinson’s Disease
by: Margarita M. Rudenok, et al.
Published: (2022-05-01)

Mitochondrial Dysfunction in Parkinson’s Disease: Focus on Mitochondrial DNA
by: Olga Buneeva, et al.
Published: (2020-12-01)

Caffeic Acid Phenethyl Ester With Mesenchymal Stem Cells Improves Behavioral and Histopathological Changes in the Rat Model of Parkinson Disease
by: Khojasteh Rahimi Jaberi, et al.
Published: (2022-09-01)

Restoration of MPTP-induced deficits by exercise and Milmed® co-treatment
by: Trevor Archer, et al.
Published: (2014-08-01)

Discovery of a Necroptosis Inhibitor Improving Dopaminergic Neuronal Loss after MPTP Exposure in Mice
by: Sara R. Oliveira, et al.
Published: (2021-05-01)

Effects of Tiliroside and Lisuride Co-Treatment on the PI3K/Akt Signal Pathway: Modulating Neuroinflammation and Apoptosis in Parkinson’s Disease
by: Faisal K. Alkholifi, et al.
Published: (2023-10-01)

Leucine‐rich repeat kinase 2 (LRRK2) inhibition upregulates microtubule‐associated protein 1B to ameliorate lysosomal dysfunction and parkinsonism
by: Kang Chen, et al.
Published: (2023-12-01)

Mitochondrial dysfunction, iron accumulation, and ferroptosis in Parkinson’s disease
by: Nahom Teferi, et al.
Published: (2023-06-01)

Application of OpenArray Technology to Assess Changes in the Expression of Functionally Significant Genes in the Substantia Nigra of Mice in a Model of Parkinson’s Disease
by: Dmitry Troshev, et al.
Published: (2023-12-01)

Rapamycin reverses ferroptosis by increasing autophagy in MPTP/MPP+-induced models of Parkinson’s disease
by: Tongyu Liu, et al.
Published: (2023-01-01)

Hallmarks and Molecular Tools for the Study of Mitophagy in Parkinson’s Disease
by: Thomas Goiran, et al.
Published: (2022-07-01)